Torii Pharmaceutical Co., Ltd. (TYO:4551)
Japan
· Delayed Price · Currency is JPY 6,340.00
-10.00 (-0.16%)
May 15, 2025, 3:30 PM JST
Torii Pharmaceutical Revenue
Torii Pharmaceutical had revenue of 14.68B JPY in the quarter ending March 31, 2025, with 9.16% growth. This brings the company's revenue in the last twelve months to 61.66B, up 9.56% year-over-year. In the year 2024, Torii Pharmaceutical had annual revenue of 60.43B with 10.59% growth.
Revenue (ttm)
61.66B
Revenue Growth
+9.56%
P/S Ratio
2.89
Revenue / Employee
104.15M
Employees
592
Market Cap
177.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 60.43B | 5.79B | 10.59% |
| Dec 31, 2023 | 54.64B | 5.74B | 11.74% |
| Dec 31, 2022 | 48.90B | 1.91B | 4.06% |
| Dec 31, 2021 | 46.99B | 5.29B | 12.68% |
| Dec 31, 2020 | 41.70B | -1.30B | -3.02% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |
Torii Pharmaceutical News
- 8 days ago - Shionogi to buy Japan Tobacco’s Torii Pharma in a deal worth over $1B - Seeking Alpha